loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

Sandra Sanchez-Roige presents at the Molecular Psychiatry Association meeting

The Molecular Psychiatry Association meeting was held in person from Maui, Hawaii (March 5-8). Sandra Sanchez-Roige presented a talk, “Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry”, as part of the symposium on Linking Mental Health and Physical Health Using Genetics, Functional Genomics, and Large Scale Electronic Health Record Data.

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING